ANTHONY B EVNIN Insider Trading Transactions
Get free email notifications about insider trading for ANTHONY B EVNIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANTHONY B EVNIN. ANTHONY B EVNIN is Director in CANTEL MEDICAL CORP ($CMN) and Director in PHARMOS CORP ($PARS) and Director in OTIX GLOBAL, INC. ($SNCI) and Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and Director in RENOVIS INC ($RNVS) and Director in MEMORY PHARMACEUTICALS CORP ($MEMY) and Director in SUNESIS PHARMACEUTICALS INC ($SNSS) and Director in ICAGEN INC ($ICGN) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Coley Pharmaceutical Group, Inc. ($COLY) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in Juno Therapeutics, Inc. ($JUNO).
Latest Insider Trading Transactions of ANTHONY B EVNIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, CMN, COLY, CNST, ICGN, INFI, JUNO, MEMY, SNCI, PARS, RNVS, SNSS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 31 2020 | CMN | CANTEL MEDICAL COR ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 1,935 | 0 | 12,132 | 10.2 K to 12.1 K (+18.98 %) |
Jun 30 2020 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 7.52 | 4,000 | 30,080 | 4,000 | |
Jun 18 2020 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 0.92 | 30,000 | 27,600 | 30,000 | |
Jun 18 2020 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 22,826 | 0 | 165,964 | 143.1 K to 166 K (+15.95 %) |
Mar 27 2020 | CMN | CANTEL MEDICAL COR ... | EVNIN ANTHONY B | Director | Buy | P | 37.40 | 1,300 | 48,620 | 10,197 | 8.9 K to 10.2 K (+14.61 %) |
Mar 27 2020 | CMN | CANTEL MEDICAL COR ... | EVNIN ANTHONY B | Director | Buy | P | 40.37 | 1,200 | 48,444 | 8,897 | 7.7 K to 8.9 K (+15.59 %) |
Mar 27 2020 | CMN | CANTEL MEDICAL COR ... | EVNIN ANTHONY B | Director | Buy | P | 37.40 | 1,300 | 48,620 | 10,197 | 8.9 K to 10.2 K (+14.61 %) |
Mar 27 2020 | CMN | CANTEL MEDICAL COR ... | EVNIN ANTHONY B | Director | Buy | P | 40.37 | 1,200 | 48,444 | 8,897 | 7.7 K to 8.9 K (+15.59 %) |
Dec 16 2019 | CNST | CONSTELLATION PHAR ... | EVNIN ANTHONY B | Director | Buy | P | 34.50 | 400,000 | 13,800,000 | 5,742,765 | 5.3 M to 5.7 M (+7.49 %) |
Oct 04 2019 | CNST | CONSTELLATION PHAR ... | EVNIN ANTHONY B | Director | Buy | P | 8.50 | 2,823,529 | 23,999,997 | 5,342,765 | 2.5 M to 5.3 M (+112.08 %) |
Aug 02 2019 | CMN | CANTEL MEDICAL COR ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 713 | 0 | 7,697 | 7 K to 7.7 K (+10.21 %) |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.60 | 30,000 | 48,000 | 30,000 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 1.60 | 13,125 | 21,000 | 143,138 | 130 K to 143.1 K (+10.10 %) |
Jun 13 2019 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 0.76 | 40,000 | 30,400 | 40,000 | |
Jun 10 2019 | CNST | CONSTELLATION PHAR ... | EVNIN ANTHONY B | Director | Option Exercise | A | 9.12 | 13,171 | 120,120 | 13,171 | |
Nov 26 2018 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Buy | P | 2.05 | 109 | 223 | 109 | 0 to 109 |
Nov 16 2018 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Sell | S | 1.82 | 151,035 | 274,400 | 0 | 151 K to 0 (-100.00 %) |
Nov 16 2018 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Sell | S | 1.86 | 670,894 | 1,248,265 | 151,035 | 821.9 K to 151 K (-81.62 %) |
Nov 16 2018 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Sell | S | 1.90 | 325,139 | 617,862 | 821,929 | 1.1 M to 821.9 K (-28.35 %) |
Aug 10 2018 | CMN | CANTEL MEDICAL COR ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 712 | 0 | 6,984 | 6.3 K to 7 K (+11.35 %) |
Jul 23 2018 | CNST | CONSTELLATION PHAR ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 10,000,000 | 0 | 0 | |
Jul 23 2018 | CNST | CONSTELLATION PHAR ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 1,208,674 | 0 | 0 | |
Jul 23 2018 | CNST | CONSTELLATION PHAR ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 888,888 | 0 | 0 | |
Jul 23 2018 | CNST | CONSTELLATION PHAR ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 664,894 | 0 | 0 | |
Jul 23 2018 | CNST | CONSTELLATION PHAR ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 3,750,000 | 0 | 0 | |
Jul 23 2018 | CNST | CONSTELLATION PHAR ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 9,500,000 | 0 | 0 | |
Jul 23 2018 | CNST | CONSTELLATION PHAR ... | EVNIN ANTHONY B | Director | Buy | P | 15.00 | 133,334 | 2,000,010 | 2,519,236 | 2.4 M to 2.5 M (+5.59 %) |
Jul 23 2018 | CNST | CONSTELLATION PHAR ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 2,385,902 | 0 | 2,385,902 | 0 to 2.4 M |
Jun 19 2018 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 2.27 | 40,000 | 90,800 | 40,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.75 | 2,000 | 3,500 | 2,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 1.75 | 11,428 | 19,999 | 130,013 | 118.6 K to 130 K (+9.64 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Option Exercise | D | 23.29 | 12,000 | 279,480 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Option Exercise | D | 42.40 | 12,000 | 508,800 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Option Exercise | D | 60.00 | 12,000 | 720,000 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Gift | G | 0.00 | 34,842 | 0 | 0 | 34.8 K to 0 (-100.00 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Gift | G | 0.00 | 25,000 | 0 | 34,842 | 59.8 K to 34.8 K (-41.78 %) |
Jan 09 2018 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 150 | 0 | 59,842 | 59.7 K to 59.8 K (+0.25 %) |
Oct 06 2017 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 161 | 0 | 59,692 | 59.5 K to 59.7 K (+0.27 %) |
Aug 01 2017 | CMN | CANTEL MEDICAL COR ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 510 | 0 | 6,272 | 5.8 K to 6.3 K (+8.85 %) |
Jul 07 2017 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Gift | G | 0.00 | 7,000 | 0 | 59,531 | 66.5 K to 59.5 K (-10.52 %) |
Jul 07 2017 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 230 | 0 | 66,531 | 66.3 K to 66.5 K (+0.35 %) |
Jun 23 2017 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 0.70 | 57,857 | 40,500 | 57,857 | |
Jun 23 2017 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 0.70 | 20,000 | 14,000 | 20,000 | |
Jun 21 2017 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Buy | P | 24.40 | 9,000 | 219,600 | 66,301 | 57.3 K to 66.3 K (+15.71 %) |
Jun 19 2017 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Option Exercise | A | 23.29 | 12,000 | 279,480 | 12,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.74 | 2,000 | 3,480 | 2,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.74 | 20,000 | 34,800 | 20,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 1.74 | 11,494 | 20,000 | 118,585 | 107.1 K to 118.6 K (+10.73 %) |
Apr 06 2017 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 311 | 0 | 57,301 | 57 K to 57.3 K (+0.55 %) |
Mar 30 2017 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Buy | J | 0.50 | 250,000 | 125,000 | 418,414 | 168.4 K to 418.4 K (+148.44 %) |
Mar 13 2017 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Buy | P | 22.11 | 8,000 | 176,885 | 56,990 | 49 K to 57 K (+16.33 %) |
Jan 19 2017 | CMN | CANTEL MEDICAL COR ... | EVNIN ANTHONY B | Director | Buy | P | 76.26 | 2,000 | 152,525 | 3,262 | 1.3 K to 3.3 K (+158.48 %) |
Jan 09 2017 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 715 | 0 | 48,990 | 48.3 K to 49 K (+1.48 %) |
Jan 09 2017 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.46 | 40,000 | 58,400 | 40,000 | |
Jan 09 2017 | CMN | CANTEL MEDICAL COR ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 1,262 | 0 | 1,262 | 0 to 1.3 K |
Oct 17 2016 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 485 | 0 | 48,275 | 47.8 K to 48.3 K (+1.01 %) |
Aug 25 2016 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Gift | G | 0.00 | 10,937 | 0 | 47,790 | 58.7 K to 47.8 K (-18.62 %) |
Jul 05 2016 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 363 | 0 | 58,727 | 58.4 K to 58.7 K (+0.62 %) |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.52 | 2,000 | 3,040 | 2,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 1.52 | 13,157 | 19,999 | 107,091 | 93.9 K to 107.1 K (+14.01 %) |
Jun 21 2016 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Option Exercise | A | 42.40 | 12,000 | 508,800 | 12,000 | |
May 31 2016 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 0.92 | 44,021 | 40,499 | 44,021 | |
May 31 2016 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 0.92 | 20,000 | 18,400 | 20,000 | |
May 17 2016 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.00 | 129,533 | 129,533 | 129,533 | |
May 17 2016 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 129,533 | 0 | 168,414 | 38.9 K to 168.4 K (+333.15 %) |
Apr 07 2016 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 364 | 0 | 58,364 | 58 K to 58.4 K (+0.63 %) |
Mar 30 2016 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Buy | P | 36.94 | 4,054 | 149,739 | 58,000 | 53.9 K to 58 K (+7.51 %) |
Mar 30 2016 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Buy | P | 36.22 | 3,946 | 142,923 | 53,946 | 50 K to 53.9 K (+7.89 %) |
Mar 30 2016 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Gift | G | 0.00 | 15,000 | 0 | 50,000 | 65 K to 50 K (-23.08 %) |
Dec 18 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Gift | G | 0.00 | 10,000 | 0 | 65,000 | 75 K to 65 K (-13.33 %) |
Sep 03 2015 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 8.60 | 2,034 | 17,492 | 93,934 | 91.9 K to 93.9 K (+2.21 %) |
Jul 29 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 47.82 | 146,614 | 7,011,081 | 0 | 146.6 K to 0 (-100.00 %) |
Jul 29 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 48.26 | 80,740 | 3,896,512 | 146,614 | 227.4 K to 146.6 K (-35.51 %) |
Jun 29 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 48.31 | 31,225 | 1,508,480 | 583,333 | 614.6 K to 583.3 K (-5.08 %) |
Jun 29 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 47.55 | 78,395 | 3,727,682 | 614,558 | 693 K to 614.6 K (-11.31 %) |
Jun 29 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 46.57 | 173,713 | 8,089,814 | 692,953 | 866.7 K to 693 K (-20.04 %) |
Jun 29 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 50.99 | 1,800 | 91,782 | 866,666 | 868.5 K to 866.7 K (-0.21 %) |
Jun 29 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 50.26 | 85,800 | 4,312,308 | 868,466 | 954.3 K to 868.5 K (-8.99 %) |
Jun 29 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 49.19 | 71,725 | 3,528,153 | 954,266 | 1 M to 954.3 K (-6.99 %) |
Jun 29 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 48.39 | 140,675 | 6,807,263 | 1,025,991 | 1.2 M to 1 M (-12.06 %) |
Jun 19 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 53.58 | 50,269 | 2,693,413 | 1,166,666 | 1.2 M to 1.2 M (-4.13 %) |
Jun 19 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 52.74 | 154,495 | 8,148,066 | 1,216,935 | 1.4 M to 1.2 M (-11.27 %) |
Jun 19 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 52.07 | 78,569 | 4,091,088 | 1,371,430 | 1.4 M to 1.4 M (-5.42 %) |
Jun 19 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 56.32 | 12,000 | 675,840 | 1,449,999 | 1.5 M to 1.4 M (-0.82 %) |
Jun 19 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 55.85 | 11,602 | 647,972 | 1,461,999 | 1.5 M to 1.5 M (-0.79 %) |
Jun 19 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 54.70 | 28,603 | 1,564,584 | 1,473,601 | 1.5 M to 1.5 M (-1.90 %) |
Jun 19 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 53.84 | 63,574 | 3,422,824 | 1,502,204 | 1.6 M to 1.5 M (-4.06 %) |
Jun 19 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 52.65 | 94,080 | 4,953,312 | 1,565,778 | 1.7 M to 1.6 M (-5.67 %) |
Jun 19 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Sell | S | 51.59 | 90,141 | 4,650,374 | 1,659,858 | 1.7 M to 1.7 M (-5.15 %) |
Jun 16 2015 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Option Exercise | A | 60.00 | 12,000 | 720,000 | 12,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 11.06 | 2,000 | 22,120 | 2,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 11.06 | 15,000 | 165,900 | 15,000 | |
Jun 01 2015 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 2.00 | 20,000 | 40,000 | 20,000 | |
Apr 06 2015 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.61 | 25,155 | 40,500 | 25,155 | |
Jan 25 2008 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.35 | 22,500 | 7,875 | 22,500 | |
Jan 07 2008 | ICGN | ICAGEN INC | EVNIN ANTHONY B | Director | Option Exercise | A | 1.55 | 5,000 | 7,750 | 5,000 | |
Jul 05 2007 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Option Exercise | A | 4.23 | 10,000 | 42,300 | 10,000 | |
Jul 23 2007 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Option Exercise | A | 2.34 | 10,000 | 23,400 | 10,000 | |
Sep 13 2007 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 9.23 | 1,875 | 17,306 | 1,875 | |
Jan 30 2007 | RNVS | RENOVIS INC | EVNIN ANTHONY B | Director | Option Exercise | A | 3.42 | 11,111 | 38,000 | 11,111 | |
Jan 19 2007 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 | |
Feb 26 2007 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Option Exercise | X | 1.33 | 129,244 | 171,895 | 0 | |
Feb 26 2007 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Option Exercise | X | 1.33 | 89,813 | 119,451 | 0 | |
Feb 26 2007 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Option Exercise | X | 1.33 | 21,905 | 29,134 | 0 | |
Feb 26 2007 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Buy | X | 1.33 | 129,244 | 171,895 | 1,859,411 | 1.7 M to 1.9 M (+7.47 %) |
Feb 26 2007 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Buy | X | 1.33 | 89,813 | 119,451 | 1,308,275 | 1.2 M to 1.3 M (+7.37 %) |
Feb 26 2007 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Buy | X | 1.33 | 21,905 | 29,134 | 293,739 | 271.8 K to 293.7 K (+8.06 %) |
Feb 08 2007 | ICGN | ICAGEN INC | EVNIN ANTHONY B | Director | Option Exercise | P | 1.45 | 217,558 | 315,459 | 217,558 | |
Feb 08 2007 | ICGN | ICAGEN INC | EVNIN ANTHONY B | Director | Option Exercise | P | 1.45 | 151,184 | 219,217 | 151,184 | |
Feb 08 2007 | ICGN | ICAGEN INC | EVNIN ANTHONY B | Director | Buy | P | 1.38 | 621,597 | 857,804 | 1,587,593 | 966 K to 1.6 M (+64.35 %) |
Feb 08 2007 | ICGN | ICAGEN INC | EVNIN ANTHONY B | Director | Buy | P | 1.38 | 431,957 | 596,101 | 1,136,812 | 704.9 K to 1.1 M (+61.28 %) |
Jan 04 2007 | ICGN | ICAGEN INC | EVNIN ANTHONY B | Director | Option Exercise | A | 1.08 | 25,000 | 27,000 | 25,000 | |
Oct 27 2006 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Buy | J | 0.00 | 25,665 | 0 | 25,665 | 0 to 25.7 K |
Oct 27 2006 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Buy | J | 0.00 | 1,026,569 | 0 | 1,026,569 | 0 to 1 M |
Oct 27 2006 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Buy | J | 0.00 | 230,978 | 0 | 230,978 | 0 to 231 K |
Oct 18 2006 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Option Exercise | P | 1.33 | 129,244 | 171,895 | 129,244 | |
Oct 18 2006 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Option Exercise | P | 1.33 | 89,813 | 119,451 | 89,813 | |
Oct 18 2006 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Option Exercise | P | 1.33 | 21,905 | 29,134 | 21,905 | |
Oct 18 2006 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Buy | P | 1.11 | 516,977 | 573,844 | 1,730,167 | 1.2 M to 1.7 M (+42.61 %) |
Oct 18 2006 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Buy | P | 1.11 | 359,255 | 398,773 | 1,218,462 | 859.2 K to 1.2 M (+41.81 %) |
Oct 18 2006 | MEMY | MEMORY PHARMACEUTI ... | EVNIN ANTHONY B | Director | Buy | P | 1.11 | 87,623 | 97,262 | 271,834 | 184.2 K to 271.8 K (+47.57 %) |
Sep 14 2006 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 15.04 | 1,875 | 28,200 | 30,000 | |
Sep 14 2006 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 15.04 | 28,125 | 423,000 | 28,125 | |
Sep 14 2006 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 13,319 | 0 | 23,530 | 10.2 K to 23.5 K (+130.44 %) |
Sep 14 2006 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 10,211 | 0 | 10,211 | 0 to 10.2 K |
Sep 14 2006 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 532,768 | 0 | 941,228 | 408.5 K to 941.2 K (+130.43 %) |
Sep 14 2006 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 408,460 | 0 | 408,460 | 0 to 408.5 K |
Sep 14 2006 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 119,763 | 0 | 211,499 | 91.7 K to 211.5 K (+130.55 %) |
Sep 14 2006 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 91,736 | 0 | 91,736 | 0 to 91.7 K |
Jun 22 2006 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Option Exercise | A | 6.01 | 10,000 | 60,100 | 10,000 | |
Jan 17 2006 | RNVS | RENOVIS INC | EVNIN ANTHONY B | Director | Option Exercise | A | 18.19 | 11,111 | 202,054 | 11,111 | |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 5,570 | 0 | 0 | |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 78,877 | 0 | 0 | |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 54,813 | 0 | 0 | |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 12,341 | 0 | 0 | |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 138,338 | 0 | 0 | |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 96,133 | 0 | 0 | |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 264,272 | 0 | 0 | |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 199,363 | 0 | 0 | |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 10,989 | 0 | 24,409 | 13.4 K to 24.4 K (+81.89 %) |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 13,420 | 0 | 13,420 | 0 to 13.4 K |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Buy | P | 7.00 | 79,650 | 557,550 | 649,955 | 570.3 K to 650 K (+13.97 %) |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 155,600 | 0 | 570,305 | 414.7 K to 570.3 K (+37.52 %) |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 150,433 | 0 | 414,705 | 264.3 K to 414.7 K (+56.92 %) |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 264,272 | 0 | 264,272 | 0 to 264.3 K |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Buy | P | 7.00 | 55,350 | 387,450 | 467,380 | 412 K to 467.4 K (+13.43 %) |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 108,129 | 0 | 412,030 | 303.9 K to 412 K (+35.58 %) |
Sep 30 2005 | SNSS | SUNESIS PHARMACEUT ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 104,538 | 0 | 303,901 | 199.4 K to 303.9 K (+52.44 %) |